AssetMark’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$70.5K Buy
3,841
+1,191
+45% +$19.7K ﹤0.01% 1759
2026
Q2
$38.7K Hold
2,650
– – ﹤0.01% 1937
2026
Q1
$19.7K Hold
2,650
– – ﹤0.01% 2063
2025
Q4
$31.2K Buy
2,650
+20
+0.8% +$216 ﹤0.01% 1862
2025
Q3
$20.3K Hold
2,630
– – ﹤0.01% 1912
2025
Q2
$19.2K Buy
+2,630
New +$21.2K ﹤0.01% 1816

Other funds holding NEO

AssetMark's NEO Position: Q3 2026 in Review

AssetMark increased its NeoGenomics (NEO) stake by 45% in Q3 2026, buying an estimated $19.7K and bringing the position to 3,841 shares worth $70.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1759.

AssetMark first reported a position in NEO in Q2 2025 and has held it in 6 quarters since. 235 funds tracked by Wall St. Rank hold NEO as of Q3 2026.

  • AssetMark held 3,841 shares of NeoGenomics worth $70.5K as of Q3 2026.
  • AssetMark bought 1,191 NeoGenomics shares in Q3 2026, an estimated $19.7K.
  • NeoGenomics made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #1759 holding.
  • AssetMark first reported a position in NeoGenomics in Q2 2025 and has held it in 6 quarters since.
  • 235 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2026.

Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.